检索结果 - Suvorov, Aleksandr

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Comparative performance of MRI-derived PRECISE scores and delta-radiomics models for the prediction of prostate cancer progression in patients on active surveillance

    Comparative performance of MRI-derived PRECISE scores and delta-radiomics models for the prediction of prostate cancer progression in patients on active surveillance 由 Sushentsev, Nikita, Rundo, Leonardo, Blyuss, Oleg, Nazarenko, Tatiana, Suvorov, Aleksandr, Gnanapragasam, Vincent J, Sala, Evis, Barrett, Tristan

    出版 2021
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  2. 2
    Cuffless Blood Pressure Measurement Using a Smartphone-Case Based ECG Monitor with Photoplethysmography in Hypertensive Patients

    Cuffless Blood Pressure Measurement Using a Smartphone-Case Based ECG Monitor with Photoplethysmography in Hypertensive Patients 由 Sagirova, Zhanna, Kuznetsova, Natalia, Gogiberidze, Nana, Gognieva, Daria, Suvorov, Aleksandr, Chomakhidze, Petr, Omboni, Stefano, Saner, Hugo, Kopylov, Philippe

    出版 2021
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  3. 3
    Carfilzomib, lenalidomide, and dexamethasone in patients with relapsed multiple myeloma categorised by age: secondary analysis from the phase 3 ASPIRE study

    Carfilzomib, lenalidomide, and dexamethasone in patients with relapsed multiple myeloma categorised by age: secondary analysis from the phase 3 ASPIRE study 由 Dimopoulos, Meletios A., Stewart, A. Keith, Masszi, Tamás, Špička, Ivan, Oriol, Albert, Hájek, Roman, Rosiñol, Laura, Siegel, David, Mihaylov, Georgi G., Goranova‐Marinova, Vesselina, Rajnics, Péter, Suvorov, Aleksandr, Niesvizky, Ruben, Jakubowiak, Andrzej, San‐Miguel, Jesus, Ludwig, Heinz, Palumbo, Antonio, Obreja, Mihaela, Aggarwal, Sanjay, Moreau, Philippe

    出版 2017
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  4. 4
    Pacritinib versus best available therapy for the treatment of myelofibrosis irrespective of baseline cytopenias (PERSIST-1): an international, randomised, phase 3 trial

    Pacritinib versus best available therapy for the treatment of myelofibrosis irrespective of baseline cytopenias (PERSIST-1): an international, randomised, phase 3 trial 由 Mesa, Ruben A, Vannucchi, Alessandro M, Mead, Adam, Egyed, Miklos, Szoke, Anita, Suvorov, Aleksandr, Jakucs, Janos, Perkins, Andrew, Prasad, Ritam, Mayer, Jiri, Demeter, Judit, Ganly, Peter, Singer, Jack W, Zhou, Huafeng, Dean, James P, te Boekhorst, Peter A, Nangalia, Jyoti, Kiladjian, Jean-Jacques, Harrison, Claire N

    出版 2017
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:

检索工具: